1. American Psychiatric Association. (1980).Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
2. Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in infantile autism: Effects on learning and behavioral symptoms.American Journal of Psychiatry, 141, 1195–1202.
3. Anderson, G. M., & Hoshino, Y. (1987). Neurochemical studies of autism. In D. J. Cohen & A. M. Donnellan (Eds.),Handbook of autism and pervasive developmental disorders (pp. 166–191). New York: Wiley.
4. Campbell, M. (1987). Drug treatment of infantile autism: The past decade. In H. Y. Meltzer (Ed.),Psychopharmacology: The third generation of progress (pp. 1225–1231). New York: Raven Press.
5. Campbell, M., & Palij, M (1985). Behavioral and cognitive measures used in psychopharmacological studies of infantile autism.Psychopharmacology Bulletin, 21(4), 1047–1053.